The Blood Grouping Reagents Market Size Value Per Capita in China has exhibited a steady upward trend from 2012 to 2022, increasing from 0.099 to 0.24 Percent US Dollars. Significant growth was observed between 2012 and 2015, with a notable spike from 0.12 to 0.18 in 2015. A consistent upward trend followed with minor fluctuations, peaking at 0.24 in 2022.
Year-on-year variation over the last two years showed an increase of 4.55% from 2021 to 2022. The five-year CAGR from 2018 to 2022 stands at approximately 3.69%, indicating a robust average annual growth rate.
Future trends to watch for include advancements in reagent technology, an increase in demand driven by a growing healthcare infrastructure, and potential shifts due to regulatory changes. Continued growth is anticipated as awareness and healthcare reach expand across China, with forecasted data suggesting this upward trajectory will persist into 2024 and beyond.
